The U.S. ambulatory surgery center market size is expected to reach USD 72.7 billion by 2033, expanding at a CAGR of 6.1% from 2026 to 2033, based on a new report by Grand View Research, Inc. The market's growth can be attributed to the reduced healthcare costs in ASCs, favorable reimbursement rates for ASCs, and a decreased risk of infection compared to hospitals.
Moreover, recently experienced notable technological advancements, prioritizing enhancing patient outcomes, cost reduction, and operational efficiency. The increasing utilization of robotics and 3D printing technology has empowered surgeons to conduct procedures with greater precision and less invasiveness, leading to swifter recovery periods and improved patient results. For instance, in July 2023, Stryker launched the Ortho Q guidance system, a robotics-ready platform.
The system has a small footprint and is designed for use in ASCs and operating rooms. Over the last decade, the demand for ASCs has increased, especially for multispecialty ASCs. This is attributed to a rise in the number of surgical procedures due to the high burden of chronic diseases in the U.S. According to ASC Data, as of Q4 2023, there were 3,072 multispecialty ASCs in the U.S. Multispecialty ASCs have the advantage of providing a wide array of quality services, competing well with hospital-owned ASCs.
Request a free sample copy or view report summary: U.S. Ambulatory Surgery Center Market Report
On the basis of application, the orthopedics segment held the largest share in 2025 due to the expansion of new procedures falling under ASC coverage, coupled with advancements in diagnostic techniques and imaging technologies within orthopedic surgeries
On the basis of ownership, the physician-owned segment dominated the market in 2025 owing to advantages linked to it including the presence of proficient physicians and their convenient accessibility
The single-specialty center type segment dominated the market with the largest revenue share in 2025 owing to the presence of a large number of single-specialty ASCs across the country
The southeast region dominated the market in 2025 owing to the high popularity of outpatient surgery and a considerable number of ASCs owned by physicians in the region
The orthopedic device type segment dominated the market in 2025. This can be attributed to the shift of orthopedic procedures to outpatient centers
In April 2026, the Leapfrog Group, an independent national nonprofit organization dedicated to patient safety, announced the expansion of its Ambulatory Surgery Center (ASC) Public Reporting Program. The redesigned initiative will include safety ratings for nearly 4,000 facilities across the U.S., beginning in July 2026
Grand View Research has segmented the U.S. ambulatory surgery center market report based on the application, ownership, center type, device type, and region:
U.S. Ambulatory Surgery Center Application Outlook (Revenue, USD Million, 2021 - 2033)
Orthopedics
Pain Management/Spinal Injections
Gastroenterology
Ophthalmology
Plastic Surgery
Otolaryngology
Obstetrics/Gynecology
Dental
Podiatry
Cardiology
Respiratory
Others
U.S. Ambulatory Surgery Center Ownership Outlook (Revenue, USD Million, 2021 - 2033)
Physician Owned
Hospital Owned
Corporate Owned
U.S. Ambulatory Surgery Center Center Type Outlook (Revenue, USD Million, 2021 - 2033)
Single-Specialty
Multi-Specialty
U.S. Ambulatory Surgery Center Device Type Outlook (Revenue, USD Million, 2021 - 2033)
Orthopedic
Gastroenterology
Ophthalmology
Dermatology
Pain Management
Cardiology
Respiratory
Others
U.S. Ambulatory Surgery Center Regional Outlook (Revenue, USD Billion, 2021 - 2033)
Southeast
West
Midwest
Northeast
Southwest
List of Key Players in the U.S. Ambulatory Surgery Center Market
Service Providers:
Envision Healthcare Corporation (KKR & CO. Inc.) LLC
Tenet Healthcare Corporation
Pediatrix Medical Group, Inc.
TeamHealth
UnitedHealth Group.
Quorum Health
Surgery Partners
Community Health Systems, Inc.
SurgCenter
Prospect Medical Systems
Edward-Elmhurst Health
Manufacturers
McKesson Corp.
BD.
Koninklijke Philips N.V.
3M
Olympus America
Abbott
Medtronic
Zimmer Biomet
Henry Schein, Inc.
STERIS Plc
"The quality of research they have done for us has been excellent..."